Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02662062
Title Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer (PCR-MIB)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Indications

bladder urothelial carcinoma

Therapies

Cisplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
Liverpool Hospital Liverpool New South Wales 2170 Australia Details
Prince of Wales Hospital Randwick New South Wales 2013 Australia Details
Royal North Shore Hospital St Leonards New South Wales 2065 Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3002 Australia Details
Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field